Endovascular techniques for the treatment of intracranial aneurysms have rapidly evolved over the past 15 years since the introduction and subsequent US Food and Drug administration approval of the Gugleilmi detachable coil. During this period, a number of different coil designs and adjunctive devices have been developed to facilitate the treatment of more complex and challenging cerebral aneurysms. One such adjunctive device, the hypercompliant occlusion balloon, can be temporarily inflated during the delivery of embolization coils to prevent their prolapse into the parent vessel. This technique, known as balloon assisted treatment (BAT), remains somewhat controversial as many operators do not incorporate this approach into their practice, favoring stent supported techniques instead. Moreover, those operators who do practice BAT use a variety of different approaches. In this review, we discuss the theoretical concepts underlying BAT, the potential advantages and disadvantages of this approach and finally the technical evolution of BAT in our endovascular practice.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
What are the major anatomical limitations of endovascular aneurysm treatment?
In general, the primary anatomical limitations faced during the coil embolization of cerebral aneurysms are those which make it difficult to densely fill the aneurysm with coils without having those same coils prolapse into the parent artery. The aneurysms which most often present these challenges fall into several (related) anatomical categories:
Wide neck. The definition of a ‘wide necked’ aneurysm varies considerably but has been described in absolute terms as having a neck measuring more than 4 mm in any dimension or, more accurately, in relative terms as having a dome: neck ratio of <1.5.1 The geometry of these aneurysms is such that the neck is often insufficient to stably retain a spherically shaped three-dimensional coil within the aneurysm fundus (figure 1). Moreover, once detached, an apparently ‘stable’ coil can subsequently prolapse out of the aneurysm into the parent artery and on occasion even embolize into the distal cerebrovasculature.
Complex anatomy at the parent artery–aneurysm interface. On occasion, the morphology of the aneurysm fundus is such that it wraps around or otherwise obscures the parent artery and precludes visualization of the parent vessel–aneurysm neck interface on one or both of the angiographic working views. As the aneurysm fundus is densely packed with embolization coils, the parent artery becomes increasingly more difficult to visualize and it becomes progressively harder to determine whether the embolization coils are being retained within the aneurysm or are extending into the parent artery. In this scenario, the inflated balloon(s) can often be used to assist in defining an optimized view of the parent artery (figure 2).
Branch arteries are incorporated into the proximal aneurysm fundus. Very wide necked aneurysms (often those occurring at bifurcations) may actually incorporate the origins of important branch arteries which arise several millimeters into the aneurysm fundus. In these cases, it is exceedingly challenging to densely fill the aneurysm fundus with embolization coils without occluding the branch vessel arising from the sac2 (figure 3).
What is balloon assisted treatment of cerebral aneurysms?
Balloon assisted aneurysm treatment (BAT; ie, balloon remodeling, balloon protection), first described concurrently by Dr Peter Kim Nelson (in the USA) and Pr Jaques Moret (in Europe), is a technique in which a temporary occlusion balloon is positioned within the parent artery across the aneurysm neck and inflated while coils are introduced into the aneurysm fundus through a second parallel catheter.3 4 The inflated balloon prevents the coil loops from herniating into the parent artery during delivery into the aneurysm. During the delivery of the framing coil, the balloon technique essentially ‘forces’ the coil to achieve its complex or spherical configuration within the confines of the aneurysm fundus. During placement of the subsequent filling coils, the balloon again prevents prolapse of the new coil during deployment but also prevents the displacement of the other previously detached coils by the new coil. Thus the balloon essentially ‘forces’ these filling coils to ‘nest’ somewhere within the structure of the pre-existing intra-aneurysmal coil mass. After a coil has been placed completely within the aneurysm, the balloon can then be deflated to ‘test’ the coil for stability. If stable, the coil can be detached. If the coil begins to prolapse after the balloon is deflated, it can be removed and repositioned. Not uncommonly, several balloon inflations and attempted deliveries are required to achieve a stable configuration of a given coil within the aneurysm (figure 4). Thus during traditional BAT, these serial inflation–deflation cycles are repeated (occasionally multiple times) for each coil until the embolization is completed.
What are the arguments in favor of BAT?
The balloon is in many aspects an optimal adjunctive device for aneurysm coil embolization for the following reasons:
Reliable parent artery protection. While inflated, the balloon provides a much more reliable and robust parent artery protection than do the available Nitinol, self-expanding, intracranial microstents (Neuroform, Boston Scientific, Fremont, California, USA; Enterprise, Codman Neurovascular, Warren, New Jersey, USA). Firstly, the contrast inflated balloon can be unambiguously visualized to demonstrate the location of the parent artery. The self-expanding stents are radiolucent and as such the exact anatomy of the interface between the parent artery and aneurysm fundus sometimes remains unclear. Hence during embolization of aneurysms with complex anatomy it is sometimes difficult to confidently ascertain whether coils are completely free of the parent artery. Secondly, the interstices of the self-expanding stents are large enough (approximately 2 French) to accommodate the unimpeded passage of a microcatheter into the aneurysm. These interstices may become even larger when the stent is deployed across an aneurysm which arises from a curved segment of the cerebrovasculature.5 The area of these interstices is sometimes sufficient to allow the prolapse of coils through the stent and into the parent artery (figure 5). In contrast with the stent, the balloon provides a completely continuous, radio-opaque barrier along the aneurysm neck. As such, unless the coiling microcatheter gets pushed out of the aneurysm or coils prolapse around the outside of the balloon (which typically indicates that the balloon is underinflated or improperly sized/shaped), there is no way that coils can come into the parent artery while the balloon is inflated.
Unambiguous parent artery visualization. Once positioned across the neck of the aneurysm, the balloon can often times provide invaluable assistance with respect to pre- (or more appropriately stated intra-) treatment planning. With the balloon inflated, the framing coil can be placed within the aneurysm but not detached. If optimally sized, the framing coil then provides a radio-opaque demarcation of the boundaries of the aneurysm. At this point, with the balloon inflated and the framing coil in place, the image intensifiers/detectors can be manipulated under fluoroscopic visualization to best depict the parent artery (demarcated by the contrast filled balloon) free of the aneurysm fundus (demarcated by the framing coil). This technique is very useful to determine the most optimal working angles for coil embolization. This is particularly useful in achieving a perfect ‘down-the-barrel’ projection of the parent artery in the region of the aneurysm neck. This ‘down-the-barrel’ projection is usually the most reliable demonstration of the parent artery boundaries during complex cases (figure 6).
Rupture protection. Intraprocedural aneurysm rupture is a potentially catastrophic complication which can often be managed and considerably mitigated using a balloon assisted technique. In the absence of an occlusion balloon, procedural aneurysm perforation usually results in immediate extravasation which can be controlled only by reversing heparinization, lowering blood pressure and quickly placing additional embolization coils. Aneurysm perforation is particularly difficult to manage in the setting of stent assisted coiling since these procedures are usually performed with the patient on dual antiplatelet therapy in addition to full procedural heparinization. During BAT, an occlusion balloon is inflated across the aneurysm neck and the lesion is essentially isolated from the cerebral circulation. Correspondingly, the inflated balloon actively prevents or minimizes any extravasation from the aneurysm should it re-rupture during the introduction of coils. If there is evidence of aneurysm rupture during coiling (eg, the coil passes outside of the confines of the aneurysm roadmap), the balloon can be left inflated while heparinization is reversed and additional coils are introduced into the aneurysm fundus. In this way the amount of extravasation which occurs after rupture can be minimized or eliminated altogether. The occlusion balloon in this scenario functions similarly to the temporary surgical clips used to control intraoperative aneurysm rupture during surgery.
Temporary device. The absolute requirement for dual antiplatelet medications represents one significant potential drawback of the application of intracranial stents for aneurysm treatment. This is particularly an issue in the setting of acute subarachnoid hemorrhage in which platelet inhibition represents a significant hazard during subsequent intensive care management.6 In contrast with stenting, BAT can be performed with heparinization alone in patients with subarachnoid hemorrhage. In some elective BAT cases, we do pretreat patients with aspirin or sometimes both aspirin and clopidogrel. These antiplatelet medications provide prophylaxis against procedural thromboembolic complications and allow the accommodation of a stent if one is ultimately deemed necessary at some point during the procedure. However, if an elective patient is pretreated with both antiplatelet agents and no intracranial stent is used, we typically discontinue clopidogrel immediately after the procedure and stop aspirin after 2–4 weeks.
Improved microcatheter access (stability and re-access). The temporary occlusion balloon can often function to stabilize the microcatheter at the aneurysm neck, preventing excessive kickback during coiling. This augmentation of microcatheter stability can facilitate dense aneurysm packing with coils. If the microcatheter should get pushed out of the aneurysm during coiling, the balloon can be deflated and it presents no barrier to aneurysm re-access. In contrast, an in situ stent frequently impairs microcatheter access into the aneurysm and also provides no additional support for the stability of the microcatheter once it is navigated into the aneurysm.
Packing density. The improved access to the aneurysm as well as the more robust nature of the parent artery protection offered by the balloon may contribute to a more aggressive coiling of the aneurysm and a higher packing density in some cases.
Dynamic parent artery protection. Initially, the balloon is sometimes inflated to the point that it herniates slightly into the aneurysm neck during coil placement. As the coiling is completed, the balloon can be inflated less aggressively to allow the coil mass to form an interface with the parent artery that exactly approximates the aneurysm neck (figure 7).
What are the potential disadvantages of BAT?
Temporary protection may be unreliable. The overriding belief which discourages some operators from using a balloon remodeling technique is the absence of a permanently implanted device to secure the coil mass in place. This raises the concern that the entire coil mass could spontaneously begin to prolapse into the parent artery at some point during the case. Once the operator gains sufficient experience with the technique, particularly when applied using the ‘conglomerate mass’ approach, it becomes evident that this is not a common or unmanageable problem. In some cases, when a very wide necked aneurysm has been densely packed down to the parent artery, the operator may elect to place a stent at the conclusion of coiling to definitively stabilize the coil mass. With this approach, one gains all of the above advantages of BAT while alleviating any concerns that the coil mass could begin to prolapse after the procedure is complete (figure 6). Similarly, if any coil prolapse is noted during the procedure, the operator retains the ability to exchange the balloon catheter for a stent delivery system.
Time. When applied using a traditional approach (ie, an inflation–deflation cycle with each coil introduction), the BAT approach can consume a considerable amount of time and require extensive manipulation of the coiling microcatheter and embolization coils. The deflation times for the balloons can last up to 15–30 s in some cases, adding a significant amount of additional time to each coil placement and detachment cycle.
Brain ischemia. While the balloon is inflated, the parent artery is completely occluded, resulting in reduced blood flow (depending on the status of the collateral circulation) and potentially ischemia of the region of brain supplied by that vessel. For this reason, it is useful to assess very closely the patterns of collateral circulation which are in place during balloon inflation. For aneurysms of the carotid artery, the balloon should be positioned specifically to avoid inducing unnecessary ischemia by occluding these collaterals. Specifically, one should avoid, when possible, having the balloon extend into the internal carotid artery terminus if the anterior communicating artery provides collateral flow or occluding the posterior communicating artery when that vessel could otherwise provide perfusion to the hemisphere. The repetitive inflation and deflation of the balloon with each coil introduction may also raise the risk of thromboembolic events by repeatedly agitating the forming coil mass and also potentially resulting in small amounts of blood being aspirated into the balloon and ultimately embolized during the procedure.
Durability of coil embolization. While BAT may allow the embolization of very wide necked aneurysms, the results may not be durable, given the propensity of these lesions to recur.7 Some operators have suggested that the application of a stent may in fact improve the durability of coil embolization by providing some degree of flow redirection and neoendothelial/overgrowth at the aneurysm–parent artery interface.8 However, there are several arguments which can be made against using a stent primarily. Firstly, the BAT likely allows a more meticulous and complete packing of the aneurysm which might lessen the risk of recanalization. Secondly, following BAT, if the operator believes that either the coil mass is unstable or otherwise requires a stent, one can be placed at that time. The balloon catheter can be exchanged over a 0.010″ 300 cm exchange microwire (eg, Xcelerator-10, eV3, Irvine, California, USA) for a microcatheter, then a 0.014″ exchange wire and ultimately a stent delivery system.
Balloon assisted coiling in our practice: the conglomerate coil mass technique
What is the ‘conglomerate mass technique’ of BAT?
Having recognized that the potential and practical limitations of balloon assisted coiling are primarily related to the repetitive cycles of inflation and deflation associated with the introduction of each coil, we began to place multiple embolization coils (3–7 coils) during each balloon inflation (typically lasting 5–10 min).
Several observations led to the evolution of this technique. Firstly, we noticed that during traditional BAT, occasionally a newly introduced coil would lead to the prolapse of a formerly placed and previously detached coil. Often times, we would continue embolization with the idea that a stent would be required at the conclusion of the coiling to secure the prolapsed coil. However, we often found that if the prolapsed loop(s) were pushed back into the aneurysm during subsequent balloon inflations and additional coils were introduced and detached, that the prolapsed loops actually enmeshed within the newly introduced coils, ultimately forming a stable intra-aneurysmal ‘conglomerate mass’ and obviating the need for a stent (figure 6).
Secondly, in some very wide necked aneurysms, we found that the original framing coil was unstable despite multiple attempts at repositioning. Moreover, even when stable within the aneurysm, the coil would frequently shift during balloon deflation. In contrast, when multiple coils were introduced and detached during the initial balloon inflation, they formed a stable intra-aneurysmal ‘conglomerate mass’ which did not appreciably shift or prolapse when the balloon(s) was ultimately deflated.
Thirdly, continuous occlusion times of between 5 and 10 min with intermittent perfusion seemed very well tolerated in most patients. In the setting of adequate direct collateral circulation (eg, robust anterior communicating artery collateral which remains patent during BAT), much longer occlusion times are acceptable. The duration of acceptable occlusion times during endovascular procedures can be extrapolated from the literature describing the application of temporary aneurysm clips during surgery. During aneurysm surgery, temporary clip occlusion times of between 5 and 10 min are routinely necessary and typically well tolerated by most patients.9 10 11 12 13 As opposed to the placement of temporary aneurysm clips, the application of an occlusion balloon as an endovascular ‘temporary clip’ is performed with full heparinization (often times with adjunctive antiplatelet medications in patients with unruptured aneurysms), does not require manipulation of the parent artery or regional perforator vessels and is not performed in conjunction with brain retraction. For these reasons, it would seem that endovascular balloon occlusion would be at least as well tolerated as temporary clip application when applied over similar time intervals.
Fourthly, during the occasional procedural rupture using traditional BAT, the conglomerate technique was used by default in an attempt to achieve complete aneurysm occlusion and halt any further hemorrhage. In these cases, it became evident that very dense packing could be achieved quite quickly using this technique.
Arguments in favor of the ‘conglomerate mass’ technique versus a traditional approach to BAT
We find in our practice that this BAT technique provides several potential advantages over the traditional approach.
The conglomerate mass created with the introduction of multiple coils was more stable than individually placed coils and allowed the coil embolization of very wide necked aneurysms without the use of an adjunctive stent (figure 3).
This approach allowed the dense packing of small, soft, finishing coils at the level of the aneurysm neck, facilitating very high packing densities and more homogeneous coil reconstructions of segmental neck defects (figure 7).
The rapid placement and detachment of multiple coils in succession shortened the overall procedural time for aneurysm coiling in comparison with the standard BAT approach (figure 8).
Placing multiple coils during a single balloon inflation allowed for fewer overall balloon inflations and less coil manipulation/repositioning. This technique likely results in shorter cumulative total balloon occlusion times in many cases.
Unexpected procedural aneurysm perforation becomes more manageable, as many coils are introduced quickly and the aneurysm is typically very well occluded at the time of the initial balloon deflation (ie, the time when procedural perforation becomes evident).
The conglomerate mass technique: technical points, equipment and procedural details
Key technical points
Anticoagulation/antiplatelet regimen: full anticoagulation is required for BAT using the conglomerate mass technique
For these cases, it is required that patients, regardless of their rupture status, are completely heparinized (activated clotting time of 250 to 300 s) prior to balloon inflation. The application of complete heparinization can be deferred until the microcatheters are in the appropriate position for the initiation of coiling. Patients with unruptured wide necked aneurysms undergoing elective embolization with BAT are pretreated with aspirin (81–325 mg/day given the morning of the procedure) and sometimes clopidogrel (75 mg/day for 5–7 days or 600 mg/day prior to the procedure with 75 mg on the morning of the procedure) particularly if stent use is anticipated. If stenting is not performed, in most cases clopidogrel can be discontinued immediately after the procedure and aspirin stopped at 2–4 weeks.
Balloon selection, positioning and navigation
Strategies for balloon selection and positioning are based on a thorough understanding of the anatomy of the aneurysm, the parent artery and the relevant adjacent branch vessels. Two general factors govern these decisions.
Firstly, the operator must define the exact volume of the parent artery and regional branch vessels (ie, the parent artery–aneurysm complex) which is at risk for coil prolapse and therefore must be protected with the balloon(s)—the ‘volume at risk’. Sometimes it is helpful to actually trace this volume out on the image. This volume will then determine which balloon(s) should be selected and where it/they should be positioned such that the required space can be completely filled during the inflations (figures 3, 6, 7 and 8).
Secondly, for bifurcation aneurysms, the operator must determine which branch(es) is(are) most likely to be occluded by the prolapse of an individual coil or the forming coil mass. This can often be done by visualizing the aneurysm completely filled by a symmetric spherical or elliptical coil mass since the favored configuration of implanted coils typically conforms to this shape. The branch vessel most likely to be occluded by the coil mass is the one which will require not only balloon protection but control via catheterization with the balloon microwire. This microwire control allows the operator to seamlessly exchange the balloon catheter for a stent delivery system in the case that coils prolapse into the orifice of the vessel during or after treatment.
The available single lumen, hypercompliant temporary occlusion balloons accommodate only a 0.010″ microwire. Given the limited torque response of the smaller 0.010″ microwires, negotiation of complex cerebrovascular anatomy with the balloon catheter can be very challenging. In addition, the balloon catheters are larger and more rigid than the standard 0.017″ internal diameter (ID) microcatheters and as such have a tendency to ‘override’ the relatively soft 0.010″ microwire in the absence of excellent distal wire purchase. For this reason, we prospectively navigate predictably difficult anatomy with a standard microcatheter and 0.014″ microwire to achieve distal access within the targeted anatomy (foregoing any attempt at primary catheterization with the balloon). We then exchange the microcatheter for the occlusion balloon of choice over a 300 cm, 0.010″ exchange length microwire (Xcelerator-10, eV3). After this exchange, we maintain the 300 cm microwire in place through the balloon catheter for the entire case, allowing for a seamless exchange to a stent delivery system should this be necessary at some point during the case.
As the stability of the conglomerate mass is predicated on the introduction of multiple coils during a single balloon inflation, it is important that the microcatheter does not get rejected from the aneurysm after only one or two coils are placed. For this reason, a stable and deep access into the aneurysm is preferable. In larger aneurysms, we have achieved this with a microcatheter position which courses around the aneurysm dome and/or through the introduction of a second microcatheter into the aneurysm for coiling (figure 8). Coils can then be introduced into the aneurysm until the microcatheter(s) is/are rejected.
Coils with rapid detachment
The rapid delivery and detachment of multiple coils requires a rapid detachment mechanism. The standard electrolytic detachment, which can require between 15 and 45 s per coil, is not compatible with the conglomerate mass technique.
Soft coils of long length
Softer coils work best with this technique as they do not reject the microcatheter from the aneurysm during their introduction. They also tend to fill the interstices within the developing coil mass and in the region of the aneurysm neck; they ‘mold’ around the outside of the balloon to form a more continuous interface at the parent artery–aneurysm neck interface (figure 8). The longer coils provide more length available to insinuate and enmesh within the forming coil mass. They also provide a greater volume of filling per coil, reducing the total number of coils introduced and thereby reducing the collective amount of time for coil preparation, loading and delivery.
Efficient coil preparation and delivery
The entire team must be fully engaged with the procedure while the balloon(s) is(are) inflated. The expected sequence of coils should be preselected and readily available from the technologist. During the introduction of one coil, the operator should be asking for the next coil which should be immediately ready for introduction as soon as the preceding coil is detached and removed. The assistants to the primary operator must be familiar with the process of coil preparation and microcatheter loading so that this can be performed as efficiently as possible. These considerations are critical to limiting time required to prepare and introduce each coil. If the time allotted to place each coil can be reduced, more coils can be successfully introduced into the aneurysm during a given inflation, the overall number of inflations required can be reduced as can the overall collective procedural time.
The original temporary occlusion balloons (Endeavor, Boston Scientific) relied on flow direction and were subsequently limited in terms of navigability. A new generation of hypercompliant, wire guided, temporary occlusion balloon catheters have been developed for use in the cerebrovasculature. These devices are now widely used for temporary vessel occlusion, angioplasty of cerebral vasospasm, mechanical disruption of thrombus in the setting of acute ischemic stroke and balloon assisted treatment of cerebral aneurysms.
In the USA, Hyperglide and Hyperform (eV3) balloons are most frequently used for BAT. These balloons accommodate a 0.010″ microwire which occludes the distal endhole of the catheter when passed out of the microcatheter tip. When a mixture of contrast–saline is injected into the proximal hub around the microwire through a rotating hemostatic valve, the injectate is directed into the balloon chamber resulting in balloon inflation. The hypercompliance of the balloon material allows for multiple inflations without a significant change in the profile of the distal catheter when the balloon is deflated (ie, the material collapses around the distal catheter and does not form ‘wings’ as would a semicompliant or non-compliant ‘wrapped’ angioplasty balloon). Also, the hypercompliant inflation profile makes for a very soft, atraumatic and ‘moldable’ balloon which can inflated such that it insinuates into adjacent vessels or the aneurysm neck.
The available balloons come in two general shapes, a conformable ball shape (eg, Hyperform 4×7 mm and 7×7 mm) which is typically used for bifurcation and terminal aneurysms, and a more cylindrically shaped tubular balloon (eg, Hyperglide 4×10, 15, 20, 30 mm) which is most often used for side wall aneurysms. These two different shaped balloons can sometimes be used in combination to achieve more extensive and complex remodeling.
Any standard 0.017″ ID microcatheter (SL-10, Boston Scientific; Echelon-10, eV3; Prowler-10, Codman Neurovascular) can be used in conjunction with the available hypercompliant balloon catheters through a standard 6F, 0.070″ ID guiding catheter system with the exception of the 7×7 mm Hyperform balloon. The 7×7 mm Hyperform balloon requires a larger guiding catheter (7 French gauge) to accommodate a parallel microcatheter.
Rotating hemostatic valve
There are a number of different options for managing the proximal aspect of the guiding catheter. The two microcatheters can be placed side by side through a single rotating hemostatic valve (RHV) port. We do not prefer this technique as this set-up makes the independent positioning of the two catheters more challenging. Two RHVs can be coupled together to provide two ports for microcatheter access but the additional RHV adds considerably to the deadspace of the guiding catheter system. Finally, a W-shaped adapter (eg, The Sequel; Cook Medical, Indianapolis, Indiana, USA) with two valve ports and a one side arm integrated into a single RHV in our opinion represents an optimal solution by minimizing deadspace and providing independent access for both microcatheters.
Diagnostic angiography is first performed to approximate the working angles for coil embolization and to obtain accurate measurements of the aneurysm fundus for coil selection. The framing coils and the anticipated filling/finishing coils are then removed from the stock and placed in an accessible position such that they may be opened and provided to the operators efficiently. The volume distribution which must be protected with the balloon(s) is determined at this point, and the appropriate balloon(s) is opened and prepared. Regardless of rupture status, full heparinization (ACT of approximately 250–300 s) is usually instituted at the time that the balloons are being inflated.
Once the balloons are in position and the aneurysm is catheterized, it is sometimes useful to inflate the balloons and partially deploy the framing coil into the aneurysm. The coil outlines the confines of the aneurysm while the contrast opacified balloon(s) demarcates the parent artery. Then, under live native fluoroscopy, the image detectors can be manipulated to demonstrate the parent arteries (demarcated by the contrast inflated balloon(s)) to best advantage as separate from the aneurysm fundus (demarcated by the aneurysm coil). This technique can be used to optimize the working angles for embolization.
At this point, the coil can be removed and the balloons deflated to allow cerebral reperfusion. A new angiographic run is performed in these optimized working angles and, if possible, displayed as a reference image which can be viewed throughout the case. The balloon(s) can then be reinflated and coils delivered into the aneurysm. During the initial inflation, typically between 3 and 7 coils can be deployed over 5–10 min depending on the aneurysm size. Following placement of these coils, a blank roadmap image can be created with the balloon(s) inflated. Then the balloon(s) can be deflated with fluoroscopic visualization on a blank roadmap. The balloon(s) deflate to form a negative defect in the region of the parent artery (figures 3 and 6). On the blank map, even the most subtle shift of the coil mass or an individual coil loop will be evident. An angiographic run is performed at this time to confirm the patency of the parent arteries and branches. Additional rounds of balloon inflation and embolization are then performed as needed. Usually the endpoint of the case is indicated when the microcatheter has been rejected from the aneurysm during the introduction of small diameter, short finishing coils (eg, 2 mm Ultipaq or DeltaPlush (Micrus Endovascular, San Jose, California, USA); 2-mm Hydrosoft or Hypersoft (Microvention/Terumo, Alisa Viejo, California, USA)). For smaller aneurysms (<7 mm) it is not uncommon that the entire embolization can be completed during a single balloon inflation.
Occlusion times accepted using this technique are longer than those traditionally used during balloon assisted coil embolization. However, certain subsets of patients may not tolerate these lengths of occlusion and caution should be exercised in these cases. The literature describing occlusion times with temporary surgical clips have indicated that older patients and those with subarachnoid hemorrhage may be at a higher risk of ischemia with temporary occlusion.9 11 12 13 14 15 Further work with procedural neuromonitoring and anesthetic optimization may make this approach safer and more effective in the future.
The technique described in the present manuscript has been derived solely from our collective clinical experience. To date, beyond our empirical observations from individual cases, there are no studies which support the conglomerate mass technique as a general approach to aneurysm coil embolization.
The balloon assisted treatment (BAT) of aneurysms offers several theoretical and practical advantages over unassisted or stent supported coil embolization. By introducing a number of coils during a single balloon inflation, the procedures may be completed more quickly with fewer balloon inflations. In addition, our clinical experience suggests that when a number of coils are placed during a single balloon inflation, they form a ‘conglomerate mass’ which is more stable than any individually placed aneurysm coil. Using this ‘conglomerate mass’ technique we have (in some cases) been able to achieve a very dense packing of wide necked and complex aneurysms without adjunctive stents.
Competing interests None.
Provenance and peer review Commissioned; not externally peer reviewed.